Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share

Key PointsRegeneron’s revenue is growing at a good clip despite declining Eylea sales.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。